Related Experiment Video
Updated: Dec 12, 2025
Imaging the Intracellular Trafficking of APP with Photoactivatable GFP
Published on: October 17, 2015
Presenilin 1 phosphorylation regulates amyloid-β degradation by microglia
Jose Henrique Ledo1, Thomas Liebmann2, Ran Zhang3
1Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY, 10065, USA. jledo@rockefeller.edu.
Abstract:
Amyloid-β peptide (Aβ) accumulation in the brain is a hallmark of Alzheimer's Disease. An important mechanism of Aβ clearance in the brain is uptake and degradation by microglia. Presenilin 1 (PS1) is the catalytic subunit of γ-secretase, an enzyme complex responsible for the maturation of multiple substrates, such as Aβ. Although PS1 has been extensively studied in neurons, the role of PS1 in microglia is incompletely understood. Here we report that microglia containing phospho-deficient mutant PS1 display a slower kinetic response to micro injury in the brain in vivo and the inability to degrade Aβ oligomers due to a phagolysosome dysfunction. An Alzheimer's mouse model containing phospho-deficient PS1 show severe Aβ accumulation in microglia as well as the postsynaptic protein PSD95. Our results demonstrate a novel mechanism by which PS1 modulates microglial function and contributes to Alzheimer's -associated phenotypes.
Insights
Presenilin 1 (PS1) in microglia is crucial for clearing amyloid-beta (Aβ) in Alzheimer's Disease. Mutant PS1 impairs microglial function, leading to Aβ accumulation and disease phenotypes.
Area of Science:
- Neuroscience
- Cell Biology
- Pathology
Background:
- Amyloid-beta (Aβ) peptide accumulation is a key feature of Alzheimer's Disease (AD).
- Microglia are critical for clearing Aβ in the brain.
- Presenilin 1 (PS1), the catalytic subunit of γ-secretase, is vital for Aβ production, but its role in microglia is not well understood.
Purpose of the Study:
- To investigate the function of Presenilin 1 (PS1) in microglia.
- To determine the impact of a phospho-deficient PS1 mutation on microglial responses and Aβ clearance.
Main Methods:
- In vivo studies using mouse models with phospho-deficient PS1 mutations.
- Assessment of microglial response to brain injury.
- Analysis of amyloid-beta oligomer degradation by microglia.
- Investigation of phagolysosome function in microglia.
Main Results:
- Microglia with phospho-deficient PS1 showed delayed responses to micro-injury in vivo.
- These microglia exhibited impaired degradation of amyloid-beta oligomers due to phagolysosome dysfunction.
- An Alzheimer's mouse model with phospho-deficient PS1 displayed significant Aβ and PSD95 accumulation in microglia.
Conclusions:
- PS1 plays a critical, previously unrecognized role in modulating microglial function.
- Dysfunctional PS1 in microglia contributes to Alzheimer's Disease-associated phenotypes by impairing Aβ clearance.
- Targeting PS1 in microglia may offer a novel therapeutic strategy for Alzheimer's Disease.
More Related Videos
09:52Modified Roller Tube Method for Precisely Localized and Repetitive Intermittent Imaging During Long-term Culture of Brain Slices in an Enclosed System
Published on: December 28, 2017
04:41Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
Published on: July 14, 2010
Related Concept Videos
03:03Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
01:12GPCR Desensitization
02:58Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
01:13The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...